DCBO Docebo Inc. IFRS
Services-Prepackaged Software · Nasdaq · SEC CIK 1829959 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY11.9%
TTM net income YoY40.3%
TTM EPS YoY48.8%
Revenue 3-yr CAGR19.3%
Net income 3-yr CAGR74.8%
Margins
Gross margin80.3%
Operating margin9.6%
Net margin15.5%
FCF margin11.2%
EBITDA margin10.9%
Returns
ROE56.9%
ROA18.9%
ROIC (approx.)—
Asset turnover1.22x
Leverage & solvency
Liabilities / assets64.1%
Debt / equity0.00x
Current ratio1.22x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.75x
Accruals ratio4.7%
Payout ratio—
Capex / revenue0.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY2025*2025-12-31 | FY2024*2024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $242.69M | $216.93M |
| Cost of revenue | $47.85M | $41.30M |
| Gross profit | $194.84M | $175.64M |
| R&D expense | $50.12M | $43.91M |
| SG&A expense | $34.70M | $32.59M |
| Operating income | $23.24M | $21.29M |
| Pretax income | $24.45M | $23.71M |
| Income tax | -$13.07M | -$3.02M |
| Net income | $37.51M | $26.74M |
| EBITDA | $26.42M | $24.68M |
| EPS (basic) | 1.31 | 0.88 |
| EPS (diluted) | 1.28 | 0.86 |
| Weighted avg. shares (diluted) | 29.37M | 30.99M |
| Balance sheet | ||
| Cash & equivalents | $74.04M | $92.54M |
| Receivables | $55.21M | $45.57M |
| Current assets | $151.52M | $154.24M |
| PP&E, netmay include right-of-use assets (IFRS) | $2.04M | $2.00M |
| Goodwill | $14.54M | $13.85M |
| Intangibles | $1.03M | $1.67M |
| Total assets | $206.65M | $190.71M |
| Current liabilities | $123.80M | $128.60M |
| Total liabilities | $132.56M | $132.95M |
| Shareholders' equity | $74.09M | $57.76M |
| Cash flow statement | ||
| Operating cash flow | $28.17M | $29.25M |
| Capital expenditure | $981,000 | $1.25M |
| Free cash flow | $27.19M | $28.00M |
| Investing cash flow | -$1.84M | -$1.50M |
| Financing cash flow | -$46.65M | -$6.84M |
| Depreciation & amortization | $3.19M | $3.38M |
| Stock-based compensation | $6.00M | $7.33M |
Free plan shows the latest 2 periods; Pro shows all 7 🔒
· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.